JAN 22, 2017 07:28 PM PST

Watching Immune Cells Cause Arthritis In Real Time

WRITTEN BY: Kara Marker

New technology allows scientists to watch immune cells move in real time, and researchers recently took advantage of this capability to understand the molecular players involved during joint inflammation for individuals with inflammatory arthritis.

Inflammatory arthritis, whether as a result of rheumatoid arthritis, lupus, or another autoimmune disease, often stems from a type III hypersensitivity, a type of reaction that is mediated by complexes of antibodies and their matching antigen. These complexes aggregate in the body tissues and result in a neutrophil-centered inflammatory response. Neutrophils are the most common type of leukocyte circulating in the bloodstream and often the first cell type to arrive on the scene of infection or inflammation.

Image: On the left, many green-labeled neutrophils carrying the C5a receptor have moved out from the grey blood vessel into the joint of a mouse in which inflammatory arthritis has been induced. In an animal lacking expression of the C5a receptor on neutrophils (right), only a few adhere to the blood vessel wall and, after quickly detaching, do not enter the joint. Credit: Yoshishige Miyabe, MD, PhD, Massachusetts General Hospital Center for Immunology and Inflammatory Diseases

 

Scientists already knew the general path neutrophils followed to reach the joints: inflammatory factors called cytokines activate endothelial cells lining adjacent blood vessels that further prompt the migration and accumulation of inflammatory neutrophils. But now a new technique, used by scientists from the Massachusetts General Hospital (MGH) Center for Immunology and Inflammatory Diseases (CIID), revealed much more about how these autoimmune reactions occur on the molecular level.

"The control of immune cell entry into the joint represents a major point at which new therapies could be developed to reduce the symptoms of inflammatory arthritis," explained senior author Andrew Luster, MD, PhD. "Imaging of the joint could help evaluate the mechanism of a drug's therapeutic effect, and if a process turns out to be mediated by more than one chemoattractant, understanding the mechanism would allow the rational design of combination therapies to completely shut down critical steps in the process."

The new imaging technique is called “multiphoton intravital microscopy,” and it was developed by fellow CIID investigator Thorsten Mempel, MD, PhD, also a co-author of the study. Luster and his team used Mempel’s method to observe moving immune cells in real time in a mouse model of rheumatoid arthritis.

"Inflammatory arthritis is caused when immune cells are recruited from the blood into the joint in a highly regulated process controlled by chemoattractants and adhesion receptors," Luster said. "But when the disease has become symptomatic, it is difficult to determine the initial steps that set off the recruitment of immune cells into the joint and the specific roles of the different chemoattractants.”

Credit: Practical Pain Management

The found that the immune complexes known to be responsible for triggering inflammation did so by prompting the production of a chemoattractant called complement C5a, a factor usually part of an innate, nonspecific immune response.

They also saw that complement C5a being displayed on the inner walls of blood vessels, which then gathered neutrophils to adhere to the vessel wall as well. After interacting with complement C5a, neutrophils continue on to the joint where they contribute to the inflammatory reaction.

Neutrophils do some of the “dirty work” themselves as well; they release interleukin-1 (IL-1), a chemical messenger that brings even more neutrophils to their location via chemokine signaling. Neutrophils also produce chemokines on their own, creating a domino effect of chemoattractant production that results in more and more neutrophils finding their way to the join to cause inflammation.

Even with bountiful new insight on how type III hypersensitivity reactions contribute to inflammatory arthritis, Luster and his team aren’t quite done. They hope to continue using multiphoton intravital microscopy to make more discoveries in the world of inflammatory arthritis. What other molecules are involved in recruiting neutrophils to the inflamed joint? What about other immune cells? How, if at all, are T cells, B cells, macrophages, dendritic cells, and others involved in type III hypersensitivity reactions? Stay tuned!

The present study was recently published in the journal Science Immunology.


Sources: Massachusetts General Hospital, Immunopathology, Immunology & Cell Biology, PubMed Health

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 03, 2018
Immunology
OCT 03, 2018
Let's Cut the Brakes on the Immune System
Two laureates receive Nobel Prize for their work regarding immune checkpoint therapy...
OCT 31, 2018
Immunology
OCT 31, 2018
Masking the Pathogen
Researchers at Penn State have revealed bacterial pathogens capable of creating components used for DNA replication without the use of metal ions allowing them to evade the immune system...
NOV 30, 2018
Immunology
NOV 30, 2018
Aspirin May Impove MS Symptoms
The medical benefits of aspirin have been known since ancient times. Hippocrates, c. 400 BC, prescribed the salicylate-rich bark and leaves of the willow t...
DEC 04, 2018
Immunology
DEC 04, 2018
Natural HIV Resistance
A team of scientists discover unique immune reactions to the one percent of HIV infected patients that are able to fend off viral propagation without antiretroviral therapy...
DEC 04, 2018
Immunology
DEC 04, 2018
Why is Skin Cancer so Elusive?
A pathway involved in skin cancer reveals a potential immunotherapy target...
JAN 15, 2019
Immunology
JAN 15, 2019
A Possible Key to Severe Flu
By studying the impact that NPY and its receptor Y1R have on influenza in mice, the research group has now discovered that NPY produced in lung phagocytes can aggravate influenza....
Loading Comments...